Home›Companies›Healthcare›RevealDx

Precision Medical Ventures Inc.

Software helps radiologists assess lung nodules on CT scans.

Updated Nov 9, 2026·Latest SEC filing Aug 12, 2026·Suggest an edit

About RevealDx

RevealDx is a private company based in Seattle, Washington. It has reported $12,716,790 raised in eight offerings on Form D since September 2021. Its chief executive is Chris Wood.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 30, 2026Aug 12, 2026$7,438,861of $7.5M target38$195KEquityRule 506(b)Form D ↗
Mar 14, 2025Mar 24, 2025$500,200of $2.0M target2$250KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Jul 24, 2024Aug 1, 2024$75,000of $1.0M target1$75,000Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Jul 5, 2024Jul 17, 2024$3,632,729fully sold60$60,545EquityRule 506(b)Form D ↗
Jan 25, 2024Feb 5, 2024$75,000of $500K target2$37,500Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Mar 24, 2023Apr 4, 2023$25,000of $750K target1$25,000Options, Securities on exerciseRule 506(b)Form D ↗
Jul 29, 2022Aug 11, 2022amended Sep 12, 2022$550,000of $1.2M target9$61,111Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Sep 15, 2021Sep 30, 2021$420,000of $500K target6$70,000Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Total, eight offerings$12,716,790

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on RevealDx's Form D filed Aug 12, 2026.

MB
Chris Wood
Chris Wood
Chief Executive Officer and director
MB
Michael Beck
Director
Michael Calhoun
Michael Calhoun
Founder and Chief Technology Officer, director
GM
Greg Mogel
Director

Sources

  1. SECPrecision Medical Ventures Inc. Form D, filed Aug 11, 2022
  2. SECPrecision Medical Ventures Inc. filing history
  3. CompanyRevealDx company
  4. CompanyRevealAI-Screen announcement